The history of the PharmaNutra Group was founded from the vision of two brothers, Andrea and Roberto Lacorte, who, in the early 2000s, decided to put together their scientific and commercial insights to change the way people approach health and well-being.
The PharmaNutra Group is currently one of the most appreciated Italian companies in the pharmaceutical and nutraceutical sector, thanks to products made with innovative and patented technologies. A forward-looking business, strengthened by a continuous and increasingly intense Research & Development activity and a constant overseas expansion. A business capable of growing and establishing itself also in the field of sport, through sponsorships of excellence, with the full awareness that at the base of every company, there must be strong financial soundness.
“PharmaNutra was founded from a dream: that of improving personal well-being starting from the properties of the micro- and macronutrients consumed through diet. We have truly believed in this, we have taken risks, we staked everything on our intuitions and on a method of our own. And we will continue to do so.”
Establishment of a new company specialised in nutraceutical raw materials.
PharmaNutra is founded, for the development of medical devices and nutraceutical products.
Launch of the company’s first proprietary brand on the market.
PharmaNutra opens to external investors to launch a new development plan.
Establishment of a new company focusing on the paediatric sector.
Signature of the first foreign distribution contract.
PharmaNutra enters the Borsa Italiana Elite programme to consolidate and accelerate its growth.
The SiderAL® r.m. patent is voted “Readers Ingredient of the Year” by the scientific journal Nutraingredients.
The PharmaNutra Group is listed on the AIM market (today Euronext Growth Milan) of the Italian Stock Exchange, through the innovative pre-booking company IPO Challenger® promoted by Electa.
SiderAL® Forte 20 capsule is the best-selling nutritional supplement in Italy (Federsalus-IQVIA data).
The PharmaNutra Group moves to the Euronext STAR Milan market of Borsa Italiana.
The new offices will hold one of the most innovative molecular biology laboratory in Europe.
